High Dose Osimertinib In Patients With Advanced Stage Egfr Exon 20 Mutation-Positive Nsclc: Results From A Phase Ii Multicenter Study, Position20 F. Zwierenga, B. A. M. H. Van Veggel,L. E. L. Hendriks, T. J. N. Hiltermann, B. I. Hiddinga, L. B. M. Hijmering-Kappelle,A-M. C. Dingemans,C. Van Der Leest,A. J. De Langen,M. Van Den Heuvel,A. J. Van Der WekkenANNALS OF ONCOLOGY（2021）引用 8|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
